✦ LIBER ✦

O3-04-06: Efficacy and tolerability of SB-742457, a novel 5HT6 receptor antagonist, in subjects with mild-to-moderate Alzheimer's disease (AD)

✍ Scribed by Marina Zvartau-Hind; Gareth Maher-Edwards; Jackie Hunter; Michael Gold; Gillian Hopton; Maria Davy; Pauline Williams

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P4-341: Efficacy and tolerability of SB-

✍ Maher-Edwards, Gareth; Dixon, Ruth; Hunter, Jackie; Gold, Michael; Hopton, Gilli 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 181 KB

48-week efficacy and tolerability of tre

✍ Maher-Edwards, Gareth; Ascher, John; Watson, Carolyn; Zvartau-Hind, Marina; Dono 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Effect of 6 months of monotherapy with t

✍ Gareth Maher-Edwards; John Davies; Kurz Alexander; Juan Schronen; Diane Boswell; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Effects of 6-month monotherapy treatment

✍ Maher-Edwards, Gareth; Zvartau-Hind, Marina; Davies, John; Alexander, Kurz; Schr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Safety, tolerability, and preliminary ef

✍ Claudine Brisard; Beth Safirstein; Kevin Booth; Lisa Hua; Yves Brault; Sangeeta 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A randomized, double-blind, placebo-cont

✍ Grove, Richard; Horrigan, Joseph; Harrington, Conn; Beresford, Isabel; Mahler, A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 102 KB